非甾体抗炎药在新型冠状病毒肺炎中的应用 - Suppr

Non-steroidal anti-inflammatory drug use in COVID-19.

作者信息

Kragholm Kristian, Torp-Pedersen Christian, Fosbol Emil

机构信息

Department of Cardiology and Unit of Clinical Biostatistics and Epidemiology, Aalborg University Hospital, 9000 Aalborg, Denmark.

Department of Cardiology, Nordsjaellands Hospital, Hillerød, Denmark.

出版信息

Lancet Rheumatol. 2021 Jul;3(7):e465-e466. doi: 10.1016/S2665-9913(21)00144-2. Epub 2021 May 7.

DOI:10.1016/S2665-9913(21)00144-2

PMID:33997799

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8104906/

Abstract

摘要

相似文献

Non-steroidal anti-inflammatory drug use in COVID-19.

Lancet Rheumatol. 2021 Jul;3(7):e465-e466. doi: 10.1016/S2665-9913(21)00144-2. Epub 2021 May 7.

Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo .

Ann Rheum Dis. 2021 Feb;80(2):e13. doi: 10.1136/annrheumdis-2020-217638. Epub 2020 Apr 30.

Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.

Ital J Gastroenterol Hepatol. 1999;31 Suppl 1:S63-72.

Upper gastrointestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use.

Aliment Pharmacol Ther. 2005 Mar 1;21(5):599-607. doi: 10.1111/j.1365-2036.2005.02378.x.

Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.

Aliment Pharmacol Ther. 2004 May 15;19(10):1051-61. doi: 10.1111/j.1365-2036.2004.01935.x.

Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects.

Dig Liver Dis. 2001 Dec;33 Suppl 2:S44-58. doi: 10.1016/s1590-8658(01)80158-4.

Low-Dose Tramadol and Non-Steroidal Anti-Inflammatory Drug Combination Therapy Prevents the Transition to Chronic Low Back Pain.

Asian Spine J. 2016 Aug;10(4):685-9. doi: 10.4184/asj.2016.10.4.685. Epub 2016 Aug 16.

Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.

Ital J Gastroenterol Hepatol. 1999;31 Suppl 1:S54-62.

Prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal mucosal injury: risk factors for serious complications.

Dig Liver Dis. 2000 Mar;32(2):138-51. doi: 10.1016/s1590-8658(00)80402-8.

Physicians' approaches to the use of gastroprotective strategies in low-risk non-steroidal anti-inflammatory drug users.

Aliment Pharmacol Ther. 2006 May 1;23(9):1365-72. doi: 10.1111/j.1365-2036.2006.02873.x.

引用本文的文献

Trends in US Pediatric Unintentional Nonprescription Cold and Cough, Analgesic and Antipyretic Drug Exposure Cases amid the COVID-19 Pandemic.

Clin Drug Investig. 2025 May 28. doi: 10.1007/s40261-025-01444-9.

Harnessing immunity: Immunomodulatory therapies in COVID-19.

World J Virol. 2024 Jun 25;13(2):92521. doi: 10.5501/wjv.v13.i2.92521.

Impact of domiciliary administration of NSAIDs on COVID-19 hospital outcomes: an unCoVer analysis.

Front Pharmacol. 2023 Oct 9;14:1252800. doi: 10.3389/fphar.2023.1252800. eCollection 2023.

Novel Molecular Consortia of Cannabidiol with Nonsteroidal Anti-Inflammatory Drugs Inhibit Emerging Coronaviruses' Entry.

Pathogens. 2023 Jul 18;12(7):951. doi: 10.3390/pathogens12070951.

Prospects of Novel and Repurposed Immunomodulatory Drugs against Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Disease.

J Pers Med. 2023 Apr 13;13(4):664. doi: 10.3390/jpm13040664.

Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions.

Eur J Drug Metab Pharmacokinet. 2023 May;48(3):221-240. doi: 10.1007/s13318-023-00826-8. Epub 2023 Apr 24.

Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms.

Vaccines (Basel). 2023 Feb 10;11(2):408. doi: 10.3390/vaccines11020408.

The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19.

NPJ Prim Care Respir Med. 2022 Sep 21;32(1):35. doi: 10.1038/s41533-022-00300-z.

Liposome encapsulated clodronate mediated elimination of pathogenic macrophages and microglia: A promising pharmacological regime to defuse cytokine storm in COVID-19.

Med Drug Discov. 2022 Sep;15:100136. doi: 10.1016/j.medidd.2022.100136. Epub 2022 Jun 13.

Self-Medication Practices in Medical Students During the COVID-19 Pandemic: A Cross-Sectional Analysis.

Front Public Health. 2022 Mar 9;10:803937. doi: 10.3389/fpubh.2022.803937. eCollection 2022.

本文引用的文献

Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study.

Lancet Rheumatol. 2021 Jul;3(7):e498-e506. doi: 10.1016/S2665-9913(21)00104-1. Epub 2021 May 7.

Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID-19.

Arthritis Rheumatol. 2021 May;73(5):731-739. doi: 10.1002/art.41593.

Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes: A Prospective Cohort Study.

Infect Dis Ther. 2021 Mar;10(1):253-268. doi: 10.1007/s40121-020-00363-w. Epub 2020 Nov 2.

Association Between Prescribed Ibuprofen and Severe COVID-19 Infection: A Nationwide Register-Based Cohort Study.

Clin Transl Sci. 2020 Nov;13(6):1103-1107. doi: 10.1111/cts.12904. Epub 2020 Oct 21.

Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19.

J Clin Med. 2020 Aug 10;9(8):2586. doi: 10.3390/jcm9082586.

Association Between Nonsteroidal Antiinflammatory Drug Use and Adverse Clinical Outcomes Among Adults Hospitalized With Coronavirus 2019 in South Korea: A Nationwide Study.

Clin Infect Dis. 2021 Dec 6;73(11):e4179-e4188. doi: 10.1093/cid/ciaa1056.

Ibuprofen use and clinical outcomes in COVID-19 patients.

Clin Microbiol Infect. 2020 Sep;26(9):1259.e5-1259.e7. doi: 10.1016/j.cmi.2020.06.003. Epub 2020 Jun 12.

Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists.

BMJ. 2020 Mar 17;368:m1086. doi: 10.1136/bmj.m1086.

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.

Nat Med. 2005 Aug;11(8):875-9. doi: 10.1038/nm1267. Epub 2005 Jul 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Non-steroidal anti-inflammatory drug use in COVID-19.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献